Abstract
Background
Nearly one-third of patients with advanced heart failure (HF) do not benefit from cardiac resynchronization therapy (CRT). We developed a novel approach for optimizing CRT via a simultaneous assessment of the myocardial viability and an appropriate lead position using a fusion technique with CT coronary venography and myocardial perfusion imaging.
Methods and Results
The myocardial viability and coronary venous anatomy were evaluated by resting Tc-99m-tetrofosmin myocardial perfusion imaging (MPI) and contrast CT venography, respectively. Using fusion images reconstructed by MPI and CT coronary venography, the pacing site and lead length were determined for appropriate CRT device implantations in 4 HF patients. The efficacy of this method was estimated by the symptomatic and echocardiographic functional parameters. In all patients, fusion images using MPI and CT coronary venograms were successfully reconstructed without any misregistration and contributed to an effective CRT. Before the surgery, this method enabled the operators to precisely identify the optimal indwelling site, which exhibited myocardial viability and had a lead length necessary for an appropriate device implantation.
Conclusions
The fusion image technique using myocardial perfusion imaging and CT coronary venography is clinically feasible and promising for CRT optimization and enhancing the patient safety in patients with advanced HF.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Because of the increase in the aging population and medical cost, an appropriate management of patients with refractory or advanced heart failure (HF) has become one of the important clinical issues to be resolved in the developed countries.1,2,3,4 In addition to the advancements in drug treatment, device implantations using implantable cardioverter-defibrillators and/or cardiac resynchronization therapy (CRT) devices have contributed to the improvement in the outcomes in patients with advanced HF.5,6,7 Roughly one-third of patients undergoing CRT, however, does not benefit from this device treatment,7,8,9,10 even though the indication criteria for CRT have regularly been revised.11,12,13 There are several proposed mechanisms behind a non-response to CRT. Overall or non-cardiac conditions can be involved in the poor outcomes in HF patients undergoing CRT. Current CRT criteria are limited in their ability to select appropriate candidates, particularly for the assessment of the grade and volume of electrical and/or mechanical dyssynchrony in the left ventricle and underlying myocardial injury in those that cannot respond to CRT. Delgado et al demonstrated that myocardial scar in the region of the LV pacing lead is an independent determinant of the long-term prognosis in ischemic HF.14 Technical approaches for device implantations are also important for achieving effective pacing for synchronization of the cardiac contraction. Functional improvement during systole with CRT is more likely to depend on the mechanical dyssynchrony of the entire left ventricle than a narrow range of the electrical dyssynchrony or single-sectional assessment by a 2D echo study.9,10
Under this context, we realized that both the assessment of the myocardial viability and appropriate selection of the pacing site in viable myocardium were indispensable for a sufficient responsiveness to CRT and prognostic improvement. Recently we developed a novel approach, named the FIVE STaR method (Fusion Image using CT Venography and perfusion SPECT applied for cardiac Resynchronization therapy), to optimize the efficacy of the CRT by discriminating CRT responders from non-responders. This method is a three-dimensional fusion technique that simply combines the two images derived from the contrast computed tomography (CT) coronary venography and gated myocardial perfusion SPECT imaging. Myocardial perfusion imaging is widely used for the assessment of inducible ischemia, myocardial viability, and cardiac event risks in patients with known or suspected coronary artery disease. On the other hand, the recent improvement in the temporal and spatial resolutions has enabled multi-slice cardiac CT imaging to clearly depict the coronary anatomy, in particular coronary vessels and coronary atherosclerotic lesions.
In this study, we applied a three-dimensional fusion imaging technique using the FIVE STaR method for the delineation of both the coronary venous system and myocardial viability via the perfusion tracer activity. This study aimed to evaluate the clinical feasibility and efficacy of this method for optimizing the CRT via a myocardial viability assessment and appropriate selection of the pacing site in patients with advanced HF.
Methods
Based on the guidelines for device treatment currently available11,12,13 and the ethical committee guidelines in our hospital, four consecutive patients were selected as CRT candidates at the heart team conference and enrolled in this study after obtaining informed consent. A defibrillation function was added in three patients using a cardiac resynchronization therapy and defibrillator (CRTD) device.
Myocardial Perfusion SPECT Imaging
At rest, myocardial perfusion SPECT imaging was performed 30 min after an intravenous injection of Tc-99m-labeled Tetrofosmin (296 MBq) in an electrocardiogram-gated (ECG) mode. A single-head gamma camera equipped with a high-resolution, parallel-hole collimator (Infinia, GE Healthcare Japan) was used to collect data at 180° (6° × 30) using the Step & Shoot method. Short-axis SPECT images were reconstructed and depicted as a polar map using serial short-axis images together with a display of the regional percent uptake (%) of the tracer activity, then a three-dimensional image was reconstructed for the following fusion imaging (Xeleris, GE Healthcare Japan).
Contrast CT Venography
CT coronary venography was performed using a 320-detector-row multi-slice CT (Aquilion ONE, Canon Medical Systems) with an image processing system (ziostation2, Ziosoft). The patients underwent an intravenous injection of contrast agent (190 mgI/kg) and beta-blockers if necessary, to keep the heart rate at less than 60 bpm. CT imaging with an ECG-gating mode was started at the time when the coronary veins were heavily stained following the Test Bolus Tracking method to reduce the radiation exposure and amount of contrast agent. In order to avoid any image distortion, motion artifact, and misregistration, the cross sections obtained during the same phase were used for the three-dimensional reconstruction and subsequent image fusion with the perfusion SPECT data. The CT images were reconstructed for each part of the left ventricle, coronary veins, right atrium, tricuspid valve, right ventricle, pulmonary artery, and spine. Then all images were integrated into one three-dimensional image.
For the appropriate placement of the pacing lead, a path was drawn along the targeted coronary vein to the suggested pacing site with viable myocardium identified by where the perfusion SPECT image overlapped. This method enabled the operators to precisely measure the pacing lead length and to three-dimensionally determine the appropriate pacing site. This method also contributed to the three-dimensional identification of the tricuspid annulus and lumbar spine, their correlations to the coronary veins on the same screen, and to the selection of an appropriate projection view for the device replacement.
CRT Device Implantation
The CRT device implantation was performed by monitoring the CT/SPECT fusion image by referring to the surrounding organs such as the vertebral canal and tricuspid valve as follows. A guiding catheter was inserted to the appropriate site in the targeted coronary vein as selected in advance, then the pacing lead was positioned using a subselection catheter (if necessary). The wire was advanced to the distal part of the coronary vein by the over-the-wire method and the lead was successfully introduced. The post-operative efficacy of the CRT was evaluated by a decrease in the left ventricular end-systolic volume (LVESV, mL), and an increase in the left ventricular ejection fraction (LVEF, %) or New York Heart Association (NYHA) functional class. The definition of a CRT responder was as follows: a 15% or more decrease in the LVESV, 5% or more increase in the LVEF, and one grade or more increase in the NYHA class at 3 months or later.
Results
In all patients, three-dimensional fusion images of the gated SPECT images and CT coronary venograms were successfully reconstructed without any definitive misregistration. Before the implantation, the fusion images enabled the operators to plan the appropriate approach to an optimal indwelling site among the coronary vein tree in which the myocardial viability was preserved with a % tracer uptake of 50% or more. The appropriate coronary vein and pacing point were selected from the CT venogram overlapped with the myocardial perfusion image, and then the appropriate curve shape and precise length of the pacing lead were successfully measured for an appropriate device implantation in all patients.
Table 1 summarizes the post-operative alterations in the LVESV, LVEF, and NYHA functional class in the 4 patients (Cases 1-4) studied here. All four patients were identified as responders to CRT (Figures 1, 2).
Discussion
This study demonstrated that the FIVE STaR method using a fusion imaging technique with CT coronary venography and myocardial perfusion SPECT successfully guided the operators in planning an effective CRT device implantation. In addition, the device treatment contributed to an improvement in the NYHA functional class and cardiac function such as in the LVESV and LVEF at least 3 months after the CRT implantation. The promising preliminary results indicated that the presented method could contribute not only to an appropriate selection of CRT responders, but also to a greater long-term efficacy of the CRT and subsequent improvement in the quality of life and outcomes in a cost-effective manner.
Myocardial Viability and CRT
Besides the several non-negligible complications due to CRT,15,16 one of the important clinical issues to be resolved is how precisely can non-responders be distinguished from CRT responders who can obtain prognostic benefits from this device treatment. The CRT efficacy depends on a sufficient viable LV myocardial mass, which can improve the global LV function by resynchronization of any heterogeneous contraction abnormalities.17 The ATP-dependent mechanism behind the myocardial uptake of nuclear tracers such as thallium-201, Tc-99m-sestamibi, and Tc-99m-tetrofosmin enables the delineation and evaluation of the myocyte viability with a tracer activity of near 50% or more, facilitating the wide use of this imaging technique over the last few decades.18,19 Dobutamine-stress echo and perfusion CT imaging with a contrast agent are also promising but still not used widely for a myocardial viability assessment. Resting gated SPECT imaging has several advantages over them as follows. Three-dimensional assessment of the entire LV segments can be performed without any dead angle from the apical-to-basal and septal-to-lateral segments and with a high reproducibility (i.e., no significant inter- or intra-observer error). Use of an iodine contrast agent or stress protocol is not necessary for a myocardial viability assessment. Moreover, recently in addition to the quantitative assessment of the global and regional LV function, three-dimensional LV mechanical dyssynchrony can be evaluated using a phase analysis.20 Thus, resting gated myocardial perfusion SPECT imaging can provide the pictorial and quantitative information necessary for an appropriate identification of a CRT candidate with advanced HF and a myocardial region that can effectively respond to synchronized pacing, leading to the improvement in the LV function and subsequent outcomes.
Coronary Venous Anatomy and CRT
Delayed imaging by coronary venography following conventional coronary angiography can be easily performed without any additional contrast agent or procedure in coronary CT imaging. The procedural planning in advance for a device implantation is important for operators to evaluate the appropriate access to an optimal pacing site and precise distance to viable myocardium among the coronary venous tree, in terms of the accessibility and effective pacing due to an appropriate pacing threshold. In addition, a precise understanding of the coronary vein anatomy prior to the implantation can contribute to the patient safety by reducing the operation time, volume of contrast agent (i.e., a risk of impairment of the kidney function), radiation exposure time, and risks for infections, bleeding, embolisms, or vein injuries15,16 related to the invasive procedures during the operation.
More technically, it is helpful for operators to safely insert a guiding catheter and pacing lead into the targeted coronary vein by understanding the positional relationship between the surrounding anatomy and ostium of the great cardiac vein connected with the peripheral veins. CT venography can provide the information about the appropriate size, length, and shape of the guiding catheter and pacing lead, and the need for a subselection catheter. In contrast, coronary veins are not clearly visualized by conventional invasive coronary angiography and a subsequent venous appearance. Invasive retrograde coronary venography with an occlusion balloon also has limitations in clearly depicting the peripheral venous anatomy. Thus, the presented FIVE STaR method can improve the over-all patient safety, procedural success rate, and probably the CRT effectiveness by its various advantages (Figure 3).
Three-Dimensional Fusion Imaging as a CRT Guide
Recent advances in CT technology21,22,23,24 such as dedicated software and improved spatial and temporal resolutions have enabled three-dimensional fusion imaging, clearly visualizing the correlation between the coronary venous anatomy and myocardial perfusion state as shown here. There have been reports of fusion of the fluoroscopy venogram and SPECT imaging.25,26 Instead of the fluoroscopic venogram, CT coronary venography using a 320-detector-row multi-slice CT was applied for the presented method. In this study, the cardiac CT and myocardial perfusion SPECT were performed separately. Although the spatial resolution between the cardiac CT and SPECT differed, this study demonstrated the sufficient accuracy of the presented method with an acceptable minimized fusion error, which may have reduced the clinical reliability. Nevertheless, misregistration may not be completely eliminated in each patient because of patient motion, uncontrollable heart rates during the CT imaging, and diffuse and/or large myocardial perfusion defects on SPECT imaging.
Limitations
This small-sized study had several issues to be resolved in a future study. A large-scale, long-term study9,27 is strongly required to clarify the clinical efficacy of the FIVE STaR method in CRT candidates with advanced HF who meet the current CRT guidelines. A randomized or case-controlled study in combination with an outcome analysis will reveal the technical value of this method for CRT device implantations. The radiation exposure from scintigraphic and CT studies as well as during the device implantation has to be lowered at each stage of this method. It will be possible by improving the imaging protocol and using a gamma camera such as a semiconductor system to reduce the over-all radiation exposure and surgical time. The echocardiographic functional parameters (LVESV and LVEF) and NYHA functional class were used for monitoring the CRT response in this study. That was because of the lack of an absolute definition of a CRT response and because those indices seemed to be clinically acceptable. As shown by our previous study using gated SPECT imaging,20 a more direct parameter of the left ventricular dyssynchrony may be useful not only for evaluating the short-term efficacy but also for predicting the long-term outcomes. Finally, an improvement in the selection of appropriate CRT candidates (or non-CRT responders), viability assessment, and surgical procedure possibly would increase not only the clinical outcomes but also the cost-effectiveness of this device treatment, even though two modalities are required. The future advancements in multi-modality systems, such as a SPECT/(high-speed, multi-slice) CT system, may make the present method more time-saving and cost-effective. This method is also promising for improving the cost-effectiveness of CRT per se via the appropriate discrimination of non-responders to CRT and reducing any unnecessary CRT device implantations together with the additional information on myocardial ischemia, which can be indicated for other therapeutic strategies.
New Knowledge Gained
We developed a novel approach, named the FIVE STaR method (Fusion Image using CT Venography and perfusion SPECT applied for cardiac Resynchronization therapy), for the optimization of CRT via a simultaneous assessment of the myocardial viability and an appropriate lead position using a fusion technique with CT coronary venography and myocardial perfusion imaging. The fusion image technique using myocardial perfusion imaging and CT coronary venography was clinically feasible and effective for CRT optimization in patients with advanced HF.
Conclusion
The three-dimensional fusion imaging named the FIVE STaR method using myocardial perfusion imaging and CT coronary venography is clinically available and promising for facilitating the CRT optimization and providing an appropriate selection of CRT candidates and technical assistant for device implantation in patients with advanced HF.
Abbreviations
- CT:
-
Computed tomography
- CRT:
-
Cardiac resynchronization therapy
- CRTD:
-
Cardiac resynchronization therapy and defibrillator
- DCM:
-
Dilated cardiomyopathy
- FIVE STaR method:
-
Fusion image using CT venography and perfusion SPECT applied for cardiac resynchronization therapy
- HF:
-
Heart failure
- LVEF:
-
Left ventricular ejection fraction
- LVESV:
-
Left ventricular end-systolic volume
- MPI:
-
Myocardial perfusion imaging
- SPECT:
-
Single photon emission computed tomography
References
Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-55. https://doi.org/10.1016/S0735-1097(99)00118-7.
Shiba N, Watanabe J, Shinozaki T, Koseki Y, Sakuma M, Kagaya Y, et al. Analysis of chronic heart failure registry in the Tohoku district: Third year follow-up. Circ J 2004;68:427-34.
Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H, CHART-2 Investigators. Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan. Circ J 2011;75:823-33. https://doi.org/10.1253/circj.cj-11-0135.
Ushigome R, Sakata Y, Nochioka K, Miyata S, Miura M, Tadaki S, et al. Temporal trends in clinical characteristics, management and prognosis of patients with symptomatic heart failure in Japan: Report From the CHART Studies. Circ J 2015;79:2396-407. https://doi.org/10.1253/circj.CJ-15-0514.
Sipahi I, Carrigan TP, Rowland DY, Stambler BS, Fang JC. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: Meta-analysis of randomized controlled trials. Arch Intern Med 2011;171:1454-62. https://doi.org/10.1001/archinternmed.2011.247.
Yancy CW, Jessup M, Bozkurt B, Buler J, Casey DE, Dazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure. J Am Coll Cardiol 2013;62:e147-239. https://doi.org/10.1016/j.jacc.2013.05.019.
Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53. https://doi.org/10.1056/NEJMoa013168.
Fox DJ, Fitzpatrick AP, Davidson NC. Optimisation of cardiac resynchronisation therapy: Addressing the problem of “non-responders”. Heart 2005;91:1000-2.
Chung ES, Leon AR, Tavazzi L, sun JP, Nihoyannopoulos P, Merlino J, et al. Results of the predictors of response to crt (prospect) trial. Circulation 2008;117:2608-16. https://doi.org/10.1161/CIRCULATIONAHA.107.743120.
Hawkins NM, Petrie MC, Burgess MI, McMurray JJV. Selecting patients for cardiac resynchronization therapy. The fallacy of echocardiographic dyssynchrony. J Am Coll Cardiol 2009;53:1944-59.
Tracy CM, Epstein AE, Darbar D, DiMarco JP, Estes SB, Dunbar NM, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol 2013;61:e6-75. https://doi.org/10.1016/j.jacc.2012.11.007.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, van der Rutten FH. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2016;37:2129-200. https://doi.org/10.1016/j.rec.2016.10.015.
Tsutsui H (2018) Guidelines for diagnosis and treatment of acute and chronic heart Failure (JCS 2017/JHFS 2017). http://www.j-circ.or.jp/guideline/pdf/JCS2017_tsutsui_h.pdf.
Delgado V, van Bommel RJ, Bertini M, Borleffs CJ, Marsan NA, Ng NC, et al. Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Circulation 2011;123:70-8. https://doi.org/10.1161/CIRCULATIONAHA.110.945345.
Romeyer-Bouchard C, Da Costa A, Dauphinot V, Messier M, Bisch L, Samuel B, et al. Prevalence and risk factors related to infections of cardiac resynchronization therapy devices. Eur Heart J 2010;31:203-10. https://doi.org/10.1093/eurheartj/ehp421.
Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: A systematic review and meta-analysis. Europace 2015;17:767-77.
Bleeker GB, Kaandorp TAM, Lamb HJ, Steendijk P, de Roos A, van der Wall EE, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006;113:969-76. https://doi.org/10.1161/CIRCULATIONAHA.105.543678.
Udelson JE, Coleman PS, Metherall J, Pandian NG, Gomez AR, Griffith JL, et al. Predicting recovery of severe regional ventricular dysfunction: Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation 1994;5:6. https://doi.org/10.1161/01.CIR.89.6.2552.
Nishisato K, Hashimoto A, Nakata T, Doi T, Yamamoto H, Nagahara D, et al. Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: Quantification of cardiac tracers in patients with ICDs. J Nucl Med 2010. https://doi.org/10.2967/jnumed.110.074971.
Doi T, Nakata T, Yuda S, Hashimoto A. Synergistic prognostic implications of left ventricular mechanical dyssynchrony and impaired cardiac sympathetic nerve activity in heart failure patients with reduced left ventricular ejection fraction. Eur Heart J Cardiovasc Imaging 2018;19:74-83. https://doi.org/10.1093/ehjci/jew334.
Schindler TH, Magosaki N, Jeserich M, Oser U, Krause T, Fischer R, et al. Fusion imaging: Combined visualization of 3D reconstructed coronary artery tree and 3D myocardial scintigraphic image in coronary artery disease. Int J Cardiac Imaging 1999;15:357-68. https://doi.org/10.1023/A:1006232407637.
Schindler TH, Magosaki N, Jeserich M, Nitzsche E, Oser U, Abdollahnia T, et al. 3D Assessment of myocardial perfusion parameter combined with 3D reconstructed coronary artery tree from digital coronary angiograms. Int J Cardiac Imaging 2000;16:1-12. https://doi.org/10.1023/A:1006216221695.
Faber TL, Santana CA, Garcia EV, Candell-Riera J, Folks RD, Peifer JW, et al. Three-dimensional fusion of coronary arteries with myocardial perfusion distributions: Clinical validation. J Nucl Med 2004;45:745-53.
Zhou W, Hou X, Piccinelli M, Tang X, Tang L, Cao K, et al. 3D Fusion of LV Venous anatomy on fluoroscopy venograms with epicardial surface on SPECT myocardial perfusion images for guiding CRT LV lead placement. JACC Cardiovasc Imaging 2014;7:1239-48. https://doi.org/10.1016/j.jcmg.2014.09.002.
Sieniewicz BJ, Gould J, Porter B, Sidhu BS, Behar JM, Claridge S, et al. Optimal site selection and image fusion guidance technology to facilitate cardiac resynchronization therapy. Expert Rev Med Dev 2018;15:555-70. https://doi.org/10.1080/17434440.2018.1502084.
Nakaura T, Utsunomiya D, Shiraishi S, Tomiguchi S, Honda T, Ogawa H, et al. Three-dimensional cardiac image fusion using new CT angiography and SPECT methods. Am J Roentgenol 2005;185:1554-7. https://doi.org/10.2214/AJR.04.1401.
Fornwalt BK, Sprague WW, Bedell P, Suever JD, Gerritse B, Merlino JD, et al. Agreement is poor among current criteria used to define response to cardiac resynchronization therapy. Circulation 2010;121:1985-91.
Disclosure
The authors have no conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The authors of this article have provided a PowerPoint file, available for download at SpringerLink, which summarises the contents of the paper and is free for re-use at meetings and presentations. Search for the article DOI on SpringerLink.com.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Tada, T., Osuda, K., Nakata, T. et al. A novel approach to the selection of an appropriate pacing position for optimal cardiac resynchronization therapy using CT coronary venography and myocardial perfusion imaging: FIVE STaR method (fusion image using CT coronary venography and perfusion SPECT applied for cardiac resynchronization therapy). J. Nucl. Cardiol. 28, 1438–1445 (2021). https://doi.org/10.1007/s12350-019-01856-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-019-01856-z